Собственный капитал и резервы Изменить Дата
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alaunos Therapeutics USD 2.15M 650K 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
IQVIA Holdings USD 6.5B 343M 2025-12
Jiangsu Hengrui CNY 63.63B 2.35B 2026-03
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Moderna USD 7.41B 1.24B 2026-03
Revvity USD 7.38B 180.27M 2025-09
Sh Fosun Pharma CNY 49.15B 248.15M 2026-03
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
Viatris USD 15.22B 352.9M 2025-09
Wuxi Apptec CNY 80.66B 9.19B 2025-12
Xeris Pharmaceuticals USD 13.69M 14.55M 2025-12
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03